Evidence map›Paper›PMID 26914942›Full record

ArticleJAMA

New Societal Approaches to Empowering Antibiotic Stewardship.

Brad Spellberg, Arjun Srinivasan, Henry F Chambers

Abstract read
In one paragraph

Article in JAMA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Trial
  2. Clinical adjudication approach for rapid diagnostics aiming to identify bacteria directly from blood.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2024
    Article
  9. Review
  10. Phytochemical Evaluation ofMolecules (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Tailored eradication strategyWorld journal of gastroenterology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brad SpellbergLos Angeles County?+?University of Southern California Medical Center, Los Angeles2Division of Infectious Diseases, Department of Medicine, Keck School of Medicine at University of Southern California, Los Angeles.
Arjun SrinivasanUS Centers for Disease Control and Prevention, Atlanta, Georgia.
Henry F ChambersDivision of Infectious Diseases, University of California at San Francisco.

Funding

Transferrin Combination Therapy to Address Antimicrobial ResistanceR01AI117211 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2016 to 2019
$2.7M
A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01R01AI103342 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DAUM, ROBERT S., LEE, JEAN CLAIRE · 2013 to 2016
$2.1M
Diabetes and Inflammation During InfectionR21AI127954 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2017 to 2018
$454k
NIAID NIH HHS R01 AI117211NIAID NIH HHS R21 AI127954
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialSocial ResponsibilityAnti-Bacterial AgentsBioethical IssuesDrug ApprovalFluoroquinolonesHumansInappropriate PrescribingPractice Guidelines as TopicProfessional AutonomyAnti-Bacterial AgentsFluoroquinolones

Identifiers

PMID26914942
PMCPMC5611826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.